Literature DB >> 17501969

A cerebellar demyelinating lesion following treatment of acne with isotretinoin.

M Yaman1, S Albayram, A Altintas, S N Yeni, N Karaagac, C Islak.   

Abstract

We report the case of a demyelinating lesion located in the left cerebellar region that developed 3 months after the onset of oral isotretinoin treatment. In April 2001, 1 year before admission, the patient underwent cranial magnetic resonance imaging (MRI) because of endocrinological problems. This was found to be completely normal. In January 2002, oral isotretinoin treatment was started to treat severe acne. Three months after the onset of therapy, the patient reported lack of appetite, faintness and tinnitus. Her second cranial MRI scan showed a cerebellar lesion, and oral isotretinoin treatment was stopped (April 2002). One month after the cessation of oral isotretinoin treatment, the lesion became less prominent on the MRI scan, and after 3 months, it had disappeared. Although it is difficult to determine the causal association between the demyelinating cerebellar lesion and isotretinoin treatment, we would like to alert physicians to this possibility, because of the common usage of this drug in daily practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17501969     DOI: 10.1111/j.1365-2230.2007.02429.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

1.  Recurrent asymptomatic demyelinating disease following 13-cis-retinoic acid exposure.

Authors:  Darin T Okuda; Michael D Prados
Journal:  BMJ Case Rep       Date:  2009-09-08

Review 2.  Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.

Authors:  Elisabeth Chroni; Alexandra Monastirli; Dionysios Tsambaos
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

3.  Tanshinone IIA inhibits the dihydrotestosterone-induced secretion of lipids and activation of sterol regulatory element binding protein-1 in HaCaT cells.

Authors:  Dong-Yan Song; Qiu-Hong Huang; Bing-Rong Zhou; Yang Xu; Zhi-Qiang Yin; Felicia Permatasari; Dan Luo
Journal:  Exp Ther Med       Date:  2012-05-22       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.